- Home
- OSS vs PRLD Comparison
OSS vs PRLD Comparison
Compare OSS & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSS
- PRLD
- Stock Information
- Founded
- OSS 1998
- PRLD 2016
- Country
- OSS United States
- PRLD United States
- Employees
- OSS N/A
- PRLD N/A
- Industry
- OSS Computer Manufacturing
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- OSS Technology
- PRLD Health Care
- Exchange
- OSS Nasdaq
- PRLD Nasdaq
- Market Cap
- OSS 62.7M
- PRLD 50.1M
- IPO Year
- OSS 2018
- PRLD 2020
- Fundamental
- Price
- OSS $2.48
- PRLD $0.82
- Analyst Decision
- OSS
- PRLD Strong Buy
- Analyst Count
- OSS 0
- PRLD 2
- Target Price
- OSS N/A
- PRLD $4.50
- AVG Volume (30 Days)
- OSS 86.9K
- PRLD 111.3K
- Earning Date
- OSS 05-07-2025
- PRLD 05-06-2025
- Dividend Yield
- OSS N/A
- PRLD N/A
- EPS Growth
- OSS N/A
- PRLD N/A
- EPS
- OSS N/A
- PRLD N/A
- Revenue
- OSS $54,301,661.00
- PRLD $7,000,000.00
- Revenue This Year
- OSS $9.65
- PRLD N/A
- Revenue Next Year
- OSS $11.43
- PRLD N/A
- P/E Ratio
- OSS N/A
- PRLD N/A
- Revenue Growth
- OSS N/A
- PRLD N/A
- 52 Week Low
- OSS $1.82
- PRLD $0.61
- 52 Week High
- OSS $4.88
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- OSS 52.83
- PRLD 50.23
- Support Level
- OSS $2.33
- PRLD $0.73
- Resistance Level
- OSS $2.90
- PRLD $1.00
- Average True Range (ATR)
- OSS 0.20
- PRLD 0.09
- MACD
- OSS 0.06
- PRLD -0.01
- Stochastic Oscillator
- OSS 54.35
- PRLD 32.60
About OSS One Stop Systems Inc.
One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bresssner segment.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.